The Role of Serum Anticholinergic Activity in ACVB Patients
NCT ID: NCT00782938
Last Updated: 2010-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2008-05-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Cognitive Dysfunction in Geriatric Patients
NCT00512200
Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery
NCT00257868
Impact of Cerebral Monitoring on Neurologic Outcome in Cardiac Surgery
NCT02006212
Older People's Neurocognitive Recovery After Cardiac Surgery
NCT06469515
Perioperative Electroencephalography Characteristics of Postoperative Delirium in Elderly
NCT03879850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low SAA
No interventions assigned to this group
high SAA
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a good knowledge in German speech
* no red/ green blindness
* no previous neurological and/or psychiatric illness
* good ability to see and to hear
* Mini-Mental-State-Examination (MMSE) better than 25 points
Exclusion Criteria
* bad knowledge in German speech
* red/ green blindness
* previous neurological and/or psychiatric illness
* no ability to see and to hear
* Mini-Mental-State-Examination (MMSE) lower than 25 points
55 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eike Martin, Prof.
Role: STUDY_CHAIR
Department of Anesthesiology, University of Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Heidelberg, Department of Anesthesiology, Heidelberg Medical School
Heidelberg, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
ISPOCD1 study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S235-2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.